Delivery Order SPE2DB22D2206-SPE2DB25FEA51

Award Date 10/31/24
Potential Completion Date 11/22/24
Potential Value $43K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $44,080.92 firm fixed price delivery order is for the supply of SAMSCA 30 MG TABLET 10S, a pharmaceutical product. The contract has an ultimate completion date of December 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of SAMSCA 15 MG TABLET 10S, a specialty medication. The firm-fixed-price delivery order, valued at $64,540.38, has a completion date of March 20, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a...
This federal contract award, valued at $10,623.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of SAMSCA 15 MG TABLET 10S, a medical product, with a performance period ending on March 13, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $10,269.78 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This contract is for the delivery of SAMSCA 15 MG TABLET 10S pharmaceutical products, with a performance period ending on March 27, 2024. Amerisourcebergen Drug Corp, a for-profit organization, has previously received numerous federal contract awards from DLA Troop Support Medical to supply pharmaceuticals,...
This federal contract award, valued at $24,768.64, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,623.60 contract is for the delivery of the prescription medication Samsca 15 mg tablets, with a performance period ending on May 14, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
This federal contract award, valued at $42,948.26, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $41,365.50 fixed-price delivery order contract has an ultimate completion date of January 14, 2025. The contract covers the supply of a range of medical products, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,464.82 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which runs through November 2026. This IDC enables the procurement of a comprehensive range of pharmaceutical products and medical supplies, including specialty...
The U.S. government has awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, valued at $13,420.30. The contract was issued by the Defense Logistics Agency (DLA) Troop Support Medical and is for the delivery of various pharmaceutical products and medical supplies. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the agency to procure...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FEA51
    Delivery Order

This federal contract award was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $42,608.40 firm-fixed-price delivery order is for the supply of SAMSCA 30 MG TABLET 10S, a specialty medication. The contract has an ultimate completion date of November 22, 2024.

Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

The contract award reviewed does not have a set-aside designation, indicating open competition.

Generated 1/30/25, 9:30 AM